NCS1 and peripheral neuropathy: These observations are in accord with the fact that the partial proteolytic degradation of NCS-1 and the loss of intracellular calcium signaling induce peripheral neuropathy associated with chemotherapy by paclitaxel (Boeckel and Ehrlich, 2018).